Organigram's Stock Rises As Canadian Pot Company's Revenue Top Analyst Estimate -- MarketWatch

Dow Jones08-13

OrganiGram Holdings Inc.'s stock $(OGI)$ was up 4% in premarket trading Wednesday after the Canadian cannabis producer reported beter-than-expected revenue. OrganiGram swung to third-quarter net income of C$2.82 million ($2.05 million), from a loss of C$213.45 million in the year-ago quarter. Net revenue increased by 25% to C$41.06 million, well ahead of the FactSet consensus estimate of $39.4 million. The company said its results were strong and that it's made inroads in the European market with a minority stake in Germany's Sanity Group GmbH. Organigram and British American Tobacco (UK:BATS) continue to work together through their product development agreement on the edible, vape and beverage businesses, as well as "new disruptive inhalation formats." Prior to Tuesday's moves, OrganiGram's stock has risen 9.9% in 2024.

-Steve Gelsi

For more from MarketWatch: http://www.marketwatch.com/newsviewer

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

August 13, 2024 07:00 ET (11:00 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment